摘要
目的分析上海市闵行区2011~2015年第二类疫苗的使用情况,为加强第二类疫苗的接种管理提供依据。方法从中国免疫规划信息系统和上海市闵行区生物制品管理信息系统中导出上海市闵行区2011~2015年第二类疫苗使用情况数据,并进行整理和描述性分析。结果 2011~2015年,上海市闵行区使用的第二类疫苗的种类基本稳定,使用量及占疫苗总使用量的比例逐年上升,分别由51.60万剂/年上升至57.82万剂/年、36.67%上升至42.48%;非本市户籍人口的第二类疫苗使用量高于本市户籍人口;可替代第一类疫苗的第二类疫苗使用总量逐年递增,总替代比例从17.92%增至36.68%,其中以A+C群流脑结合疫苗替代A群流脑多糖疫苗比例最高。结论2011~2015年上海市闵行区第二类疫苗使用品种多、使用数量大,有效地预防和控制了疫苗可预防疾病的发生。
Objective To analyze the application of vaccines of class Ⅱ in Minhang District, Shanghai City, China during 2011 - 2015, and to provide a basis for strengthening the vaccination service management of the vaccines. Methods Data on application of vaccines of class Ⅱ in Minhang District from 2011 to 2015 were derived from the China Immunization Information System and the Biological Product Management Information System for descriptive analysis. Results In 2011 - 2015, the kinds of vaccines of class 1/ used in Minhang District remained stable. However, the amounts used and the proportion in total vaccines used increased from 516 000 to 578 200 doses and from 36. 67% to 42. 48% respectively. The amount used of vaccines of class Ⅱ in floating population was higher than that in local population. The amount used of vaccines of class Ⅱ as substitutes of those of class I increased year by year, while the substitution rate ＇increased from 17. 92% to 36. 68%. However, the substitution rate of groups A ＋ C to group A meningoeoccal conjugate vaccine was the highest. Conclusion Varieties of vaccines of class Ⅱ were used in a large quantity in Minhang District during 2011 - 2015, which prevented and controlled the vaccine preventable diseases effectively.
出处
《中国生物制品学杂志》
CAS
CSCD
2018年第2期166-169,176,共5页
Chinese Journal of Biologicals
关键词
疫苗
第二类疫苗
使用情况
Vaccine
Vaccines of class H
Application
